Inflammatory and mental health sequelae of COVID-19.
Inflammatory and mental health sequelae of COVID-19.
复制标题
Covid-19的炎症和心理健康后遗症。
DOI:
10.1016/j.cpnec.2023.100186
复制
发表时间:
2023-08
影响因子:
--
通讯作者:
Moorman, Jonathan
中科院分区:
文献类型:
--
作者:
Loftis, Jennifer M.;Firsick, Evan;Shirley, Kate;Adkins, James L.;Sano, Emily;Hudson, Rebekah;Moorman, Jonathan
The COVID-19 pandemic has caused significant negative consequences to mental health. Increased inflammatory factors and neuropsychiatric symptoms, such as cognitive impairment (“brain fog”), depression, and anxiety are associated with long COVID [post-acute sequelae of SARS-CoV-2 infection (PASC), termed neuro-PASC]. The present study sought to examine the role of inflammatory factors as predictors of neuropsychiatric symptom severity in the context of COVID-19. Adults (n = 52) who tested negative or positive for COVID-19 were asked to complete self-report questionnaires and to provide blood samples for multiplex immunoassays. Participants who tested negative for COVID-19 were assessed at baseline and at a follow-up study visit (∼4 weeks later). Individuals without COVID-19 reported significantly lower PHQ-4 scores at the follow-up visit, as compared to baseline (p = 0.03; 95% CI-1.67 to −0.084). Individuals who tested positive for COVID-19 and experienced neuro-PASC had PHQ-4 scores in the moderate range. The majority of people with neuro-PASC reported experiencing brain fog (70% vs. 30%). Those with more severe COVID-19 had significantly higher PHQ-4 scores, as compared to those with mild disease (p = 0.008; 95% CI 1.32 to 7.97). Changes in neuropsychiatric symptom severity were accompanied by alterations in immune factors, particularly monokine induced by gamma interferon (IFN-γ) (MIG, a. k.a. CXCL9). These findings add to the growing evidence supporting the usefulness of circulating MIG levels as a biomarker reflecting IFN-γ production, which is important because individuals with neuro-PASC have elevated IFN-γ responses to internal SARS-CoV-2 proteins. Severity of anxiety symptoms reduced over time in adults who tested negative for COVID-19. In adults negative for COVID-19, less anxiety was accompanied by decreases in inflammatory factors. Adults with neuro-PASC had depression scores in the moderate-severe range. Adults with more severe COVID-19 reported significantly greater depression. Adults with more severe COVID-19 had higher plasma levels of monokine induced by interferon gamma.
登录
查看更多内容
影响因子:
3.7
作者:
Saeed, Banaz;Ismael, Saween A.;Amin, Redar Muhmed P.;Mahmud, Nasraw Mustafa;Al-Banna, Dara;Shabila, Nazar
通讯作者:
Shabila, Nazar
影响因子:
3.1
作者:
Camacho-Arroyo I;Flores-Ramos M;Mancilla-Herrera I;Cruz FMC;Hernández-Ruiz J;Diaz GP;Labonne BF;Del Pilar Meza-Rodríguez M;Gelman PL
通讯作者:
Gelman PL
影响因子:
3
作者:
Earnshaw, Valerie A.;Brousseau, Natalie M.;Fox, Annie B.
通讯作者:
Fox, Annie B.
影响因子:
56.9
作者:
KARUPIAH, G;XIE, QW;MACMICKING, JD
通讯作者:
MACMICKING, JD
影响因子:
4.6
作者:
Bliddal S;Banasik K;Pedersen OB;Nissen J;Cantwell L;Schwinn M;Tulstrup M;Westergaard D;Ullum H;Brunak S;Tommerup N;Feenstra B;Geller F;Ostrowski SR;Grønbæk K;Nielsen CH;Nielsen SD;Feldt-Rasmussen U
通讯作者:
Feldt-Rasmussen U